Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Pernilla Wikstrom"'
Autor:
Maria Nilsson, Christina Hägglöf, Peter Hammarsten, Elin Thysell, Pär Stattin, Lars Egevad, Torvald Granfors, Emma Jernberg, Pernilla Wikstrom, Sofia Halin Bergström, Anders Bergh
Publikováno v:
PLoS ONE, Vol 10, Iss 10, p e0140985 (2015)
Lysyl oxidase (LOX) has been shown to both promote and suppress tumor progression, but its role in prostate cancer is largely unknown. LOX immunoreactivity was scored in prostate tumor epithelium, tumor stroma and in the tumor-adjacent non-malignant
Externí odkaz:
https://doaj.org/article/a3abacd574194e6c88dd8d66a3ef94f0
Autor:
Petra Henning, Ali Kassem, Anna Westerlund, Pernilla Lundberg, Cecilia Engdahl, Vikte Lionikaite, Pernilla Wikström, Jianyao Wu, Lei Li, Catharina Lindholm, Pedro P. C. de Souza, Sofia Movérare-Skrtic, Ulf H. Lerner
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
It is well established that inflammatory processes in the vicinity of bone often induce osteoclast formation and bone resorption. Effects of inflammatory processes on bone formation are less studied. Therefore, we investigated the effect of locally i
Externí odkaz:
https://doaj.org/article/336269047b1142138c0c06e32ee49a03
Publikováno v:
Journal of Translational Medicine, Vol 21, Iss 1, Pp 1-14 (2023)
Abstract Background Prostate cancer (PC) is a heterogenous multifocal disease ranging from indolent to lethal states. For improved treatment-stratification, reliable approaches are needed to faithfully differentiate between high- and low-risk tumors
Externí odkaz:
https://doaj.org/article/34429af7d043452f982ccd3e04f70b89
Autor:
Johan Wänman, Kasim Abul-Kasim, Julius Semenas, Elin Thysell, Anders Bergh, Pernilla Wikström, Sead Crnalic
Publikováno v:
European Urology Open Science, Vol 48, Iss , Pp 44-53 (2023)
Background: Prostate cancer spinal bone metastases can have a radiographic profile that mimics multiple myeloma. Objective: To analyse the presence and prognostic value of myeloma-like prostate cancer bone metastases and its relation to known clinica
Externí odkaz:
https://doaj.org/article/663aaae897454f51885b906ab47fb96b
Autor:
Elin Thysell, Linda Köhn, Julius Semenas, Helena Järemo, Eva Freyhult, Marie Lundholm, Camilla Thellenberg Karlsson, Jan‐Erik Damber, Anders Widmark, Sead Crnalic, Andreas Josefsson, Karin Welén, Rolf J. A. Nilsson, Anders Bergh, Pernilla Wikström
Publikováno v:
Molecular Oncology, Vol 16, Iss 4, Pp 846-859 (2022)
To improve treatment of metastatic prostate cancer, the biology of metastases needs to be understood. We recently described three subtypes of prostate cancer bone metastases (MetA‐C), based on differential gene expression. The aim of this study was
Externí odkaz:
https://doaj.org/article/65f5c75dc7eb47b6a1f8e39de3159faa
Autor:
Ilona Dudka, Elin Thysell, Kristina Lundquist, Henrik Antti, Diego Iglesias-Gato, Amilcar Flores-Morales, Anders Bergh, Pernilla Wikström, Gerhard Gröbner
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-17 (2020)
Abstract Background Prostate cancer (PC) can display very heterogeneous phenotypes ranging from indolent asymptomatic to aggressive lethal forms. Understanding how these PC subtypes vary in their striving for energy and anabolic molecules is of funda
Externí odkaz:
https://doaj.org/article/080966912352427d9768afd0ab60ea79
Autor:
Elin Thysell, Linda Vidman, Erik Bovinder Ylitalo, Emma Jernberg, Sead Crnalic, Diego Iglesias‐Gato, Amilcar Flores‐Morales, Pär Stattin, Lars Egevad, Anders Widmark, Patrik Rydén, Anders Bergh, Pernilla Wikström
Publikováno v:
Molecular Oncology, Vol 13, Iss 8, Pp 1763-1777 (2019)
Bone metastasis is the lethal end‐stage of prostate cancer (PC), but the biology of bone metastases is poorly understood. The overall aim of this study was therefore to explore molecular variability in PC bone metastases of potential importance for
Externí odkaz:
https://doaj.org/article/0bd093ff3c7f4e92a8ab6f49ee9111c2
Publikováno v:
Endocrine Connections, Vol 6, Iss 8, Pp 146-161 (2017)
Prostate cancer (PC) remains a leading cause of cancer-related deaths among men worldwide, despite continuously improved treatment strategies. Patients with metastatic disease are treated by androgen deprivation therapy (ADT) that with time results i
Externí odkaz:
https://doaj.org/article/936599725e5b4af7bedd97606bdda062
Publikováno v:
Tumor Biology, Vol 39 (2017)
Previous studies have suggested that leukocyte telomere length is associated with risk of developing prostate cancer. Investigations of leukocyte telomere length as a prognostic factor in prostate cancer are, however, lacking. In this study, leukocyt
Externí odkaz:
https://doaj.org/article/fc24e626bcfc46e7afe3ccf890bbef0b
Autor:
Sofia Halin Bergström, Maria Nilsson, Hanibal Adamo, Elin Thysell, Emma Jernberg, Pär Stattin, Anders Widmark, Pernilla Wikström, Anders Bergh
Publikováno v:
PLoS ONE, Vol 11, Iss 6, p e0157280 (2016)
Aggressive tumors induce tumor-supporting changes in the benign parts of the prostate. One factor that has increased expression outside prostate tumors is hemoxygenase-1 (HO-1). To investigate HO-1 expression in more detail, we analyzed samples of tu
Externí odkaz:
https://doaj.org/article/90173ad0d3a74cb2b636aa09993af10c